Thyroid problems in pediatric oncology : damage, prevention and consequences van Santen, H.M.
Introduction n
Thyroidd damage as late adverse event after head/neck irradiation has been extensively reported,, which can result in thyroid dyshormonogenesis or dysmorphogenesis ,H . The latencyy time between radiation exposure and the clinical, biochemical or morphological expressionn of thyroid damage can vary from several months to many years 6, '\ Due to awarenesss of these late effects, the use of radiotherapy is limited whenever possible '".
Otherr preventive actions are reducing the total dose, (hyper) fractionation, reducing the sizee of the radiation-field and placing protective lead blocks u -n . Because radiotherapy remainss indispensable in the treatment of childhood cancer, prevention of thyroid damagee must be investigated by alternative ways, for example by endocrine intervention.
Inn animals as well as in humans, radiation effects on thyroid tissue are dose-dependent.
Thee occurrence of hypothyroidism increases linearly with increasing radiation dose 5J \ inn rats after doses of 12-20 Gy, a reduction of goitrogenic growth is seen, indicating losss of thyroid cells, and in children hypothyroidism is frequent after doses exceeding 255 Gy, For carcinoma, in children, the risk increases from 0.1 Gy, and levels off after 100 Gy (in children irradiated for benign diseases y ) or after 60 Gy (children with malignanciess !4 ). In rats, the dose-response curve for radiation-induced thyroid tumors hass its maximum after about 11 Gy of X-rays AA major role contributing to the pathogenesis of thyroid tumors has been ascribed to thee level of plasma thyroid stimulating hormone (TSH). It has been demonstrated, in rats,, that radiation-susceptibility of the thyroid is increased when TSH during radiation iss increased ,H,iy . In contrast, after hypophysectomy no thyroid tumors developed at all,, suggesting that the absence of TSH prevents against the development of thyroid tumorss 20 . TSH can also be suppressed by the administration of thyroxine (TJ 21 .
Koritnikk demonstrated, in rats, that administration of T 4 during irradiation resulted in aa lower incidence of thyroid tumors 22 . However, data of 9 out of 20 animals in the T
4
groupp were lacking and no results on thyroid function were given. In humans, the administrationn of T 4 during exposure to X-radiation did not prevent hypothyroidism
1} .
However,, in this study it was impossible to say anything about the occurrence of thyroidd tumors, because the follow-up time was too short. Considering these partially contradictivee results and the fact that the studies on endocrine intervention to prevent X-radiationn induced thyroid damage are limited, our aim was to evaluate different endocrinee preventive strategies in a pre-clinical in vivo model.
Forr this study, we postulated three ways ot endocrine prevention. The first is the administrationn of T 4 to suppress TSH levels. As clinical hyperthyroidism is not a favorablee state in children with malignant diseases, however, our aim would be to lower,, but not suppress TSH during irradiation. The second way is the administration off high doses of (stable) iodide, which inhibit the thyroid's activity (also known as the Wblff-Chaikofff effect) and might make the thyroid tissue less radiosensitive. The third wayy is the administration ot high doses of (cold) iodide with simultaneous administrationn of T . The acute phase of the VXolff-Chaikoff effect might be radioprotective,, but will result in a sudden fall of the plasma T, concentration due to inhibitionn of the iodide organification i4 . Due to this decrease in plasma T 4 , the level off TSH will increase, which will counteract the protective effect. This rise in TSH can bee prevented by simultaneous administration of T 4 .
Ass both hypothyroidism and thyroid carcinoma are important late effects of radiation treatmentt in clinical practice, a rat model was chosen in which both these late effects, with seriall plasma hormone measurements and evaluation of thyroid tissue could be evaluated.
Materialss and Methods

Animalss and radiation model
Forr the experiments, 80 W'istar strain rats, all male, were used. All experiments were approvedd by the Animal Ethical Committee of the Academic Medical Center (AMC)
andd were performed according to the Dutch Law for animal experiments.
Thee animals arrived at four weeks of age. After a week or acclimatization, the experimentss were started. Rats were divided into 5 groups of 16 rats each (figure 1), andd were housed in groups with tap water and food ad libidum (1 lope Farms, irradiated breedingg and maintenance diet for rats, mice and hamsters, Woerden, The Netherlands).
Meann room temperature was 22 " C, relative air humidity 55-60 %, animals were subjectedd to a 12-h light: 12-h dark cycle. F^ach rat was given an earmark.
Whenn the rats were six weeks of age, the irradiation was given. During the irradiation experiments,, animals were anesthetized by halothane inhalation. Short anesthesia was
'' l ; -s' * ** n* r ™ n f o r X r . Sixx weeks after irradiation, half of each group was sacrificed. All other rats were sacrificedd 54 weeks after irradiation. Study design All rats were given daily injections intra-pentoneal. If no endocrine intervention was given,, an injections was given with placebo (saline/ NaCI IÏ.9 . After 1 week of injection, X-Radiation fXR) wass given.' T 4 administration was given daily, starting one week before \R, 2 Nal administration was given daily, starringg one day before XR, 'T^ administration was given daily, until wu weeks after XR, 4 \al administration wass given daily, until one week after XR, I 7 up= follow-up time.
Endocrinee interventions (figure 1)
Al]] rats were given daily intraperitoneal injections, (0.004 ml per gram body-mass) startingg one week before until two weeks after irradiation, alternating on the right and leftt side of the abdomen. Groups 1 and II received placebo (NaCl 0.9 %). Group III wass given injections with 20 (Ig T 4 /100 g per day during 3 weeks. Group IV received 200 fig T /100 g per day, also starting one week before irradiation until two weeks thereafter,, together with Nal (10 mg ,2 T per day) during 1 week, starting the day beforee irradiation. Group V received Nal, for 7 days, starting the day before irradiation.
Onn the days that rats of group V did not receive Nal, sham-injections were given with saline,, so that all rats received injections during a period of three weeks.
Clinicall examination
Alll rats were scored daily by examination of body-mass, activity, fur (shiny/ fade/ hairs upright)) and skin (loss of hair/redness/wounds) condition at the irradiation site.
Thyroidd function
Inn the first 6 weeks, weekly blood samples were collected for measurement of plasma T 4
andd TSH concentrations. From six weeks after irradiation, these determinants were measuredd monthly. At sacrifice after 54 weeks, plasma TSH, T, and T 3 were measured.
TT and T\ were determined by an in-house radio immuno-assay, and TSH by a chemilumincscentt immuno-assay adapted for rat TSH (Immulite, Diagnostic Products
Corp.,, Los Angeles, CA). Intra-assay variation T 4 2 -4 %, T, 3 -4 %, and TSH 2-4 %.
Inter-assayy variation T 4 
Statisticall analysis
Dataa were analyzed using MS Excel '00 and SPSS 11.5.1 Statistics UK software.
Differencess between group 1 against all other groups were tested, and the differences betweenn group II and the other groups which received different kinds of thyroid protectionn (group III-V), and the differences between the three groups was tested.
Statisticall analysis for numeric data was performed using the Student's t-test (parametric)
andd Mann Whitney U, 2-independent test (non-parametric data). For nominal data, statisticss were performed using Chi-square tests. Follow-up data on multiple thyroid functionn determinants were analyzed using LSD, repeated measures. The level of statisticall significance was set at p<0.05.
Results s Thyroidd function before X4rradiation (XR)
Meann plasma concentration of TSH of all animals one week before XR was 1.1 mU/L (rangee 0.7-2.7) and of T 4 it was 62 mmol/L (range 48-83).
Concentrationss of plasma TSH and T 4 during endocrine interventions
Meann concentrations of plasma TSH and T in the 5 different groups during the endocrinee interventions and exposure to irradiation are shown in table 1. Due to injectionss with T a significant decrease in mean TSH concentration is found in group IIII compared to group I (p = 0.001) and compared to group II (p=0.05). In both groupss that were given T , significant increases in mean T concentrations were found (bothh p < 0.000). In group V, a significant increase of TSII was observed (p < 0.000),
withh a significant decrease of T (p < 0.000) compared to groups I and II. Duringg the weeks of endocrine interventions following the irradiation, the mean concentrationn ot TSH staved significantlv lower in group III compared to group II, butt was not suppressed (figure 2). Also in the rats of group IV (compared to group II) inn the weeks following radiation, during the endocrine intervention significant higher levelss of T 4 are found, with significant lower levels of TSH.
Clinicall and macroscopic morphological findings during follow-up
Thee mean weight of all rats at 5 weeks of age was 132 grams (range 109-199). Rats in groupp I had the lowest mean body-mass (mean 123 g) and group V the highest (mean 1400 g). These differences were not significant. After 6 weeks and 1 year, significant differencess in body-mass were found between group I and groups II to V (mean weightt gain after 6 weeks 202 and 144 g, and after 1 year 405 and 327 g resp.), but not Endocrinee intervention for X-radiation protection of the thyroid Duringg follow-up of one year, all sham-irradiated rats of group I remained healthy. In thee other groups, the following clinical signs or macroscopic abnormalities were observed: :
Groupp II: one was panting at sacrifice, one had developed a cornitying epithelioma on thee back of the neck and died 1 month before the end of the study-period due to a large andd aggressive fibrosarcoma growing around the esophagus and trachea and with lung metastases;; in two animals the thyroid gland was palpably enlarged, in 1 rat multiple suspectt (slightly enlarged) lymph nodes were found at sacrifice (microscopically normal).
Groupp III: one rat (of the short term group) was lost during an anesthesia procedure;
anotherr rat died 4 days before the end of the study-period and showed, at obduction, aa large tumor in the neck (most probably fibrosarcoma) and lung bleeding. No further thyroidd histology could be obtained due to autolysis.
Groupp IV: in two rats large tumors were palpable in the neck, one of which had grownn into the skin. Yet the animals did not show signs of illness. A 3 rd rat had a tumorr on the right shoulder. In 2, the tumors appeared to be mamma carcinoma and onee was a large malignant fibrous histiocytoma.
Groupp V: one rat had severe body-mass loss and appeared ill at sacrifice (no microscopic explanationn tound, in according to protocol selected samples). Afterr stopping the endocrine interventions, TSH increased in all irradiated groups (maximumm value 13.3 mU/L) with a fall of plasma T, (minimum value 42 mmol/L).
Inn the groups given T., the rise in TSH appeared to be slower than in the other groups,, although this was not statistically significant. Six weeks after radiation exposure (44 weeks after stopping the endocrine intervention), no significant differences were foundd between the mean concentration of TSH and of T 4 of groups II, III, IV or V. 
Histologicall evaluation of thyroid tissue
ThyroidThyroid histology after 6 weeks
Inn the thyroid glands, 6 weeks after radiation exposure, no hyperplasia, adenoma, carcinomaa or thyroiditis were observed. Between group I and the other groups, significantt differences were found in colloid density for all groups and in the activity indexx for groups II, IV and V. No significant difference w 7 as found in the activity indexx for group I and group III.
Noo significant differences were found between the irradiated groups in any of the histologicc classification points.
ThyroidThyroid histology after 1 year
Regardingg the cell activity indices of the thyroid, only significant differences were foundd between the sham irradiated rats and each of the other groups. No differences weree found between the irradiated groups given saline or any kind of endocrine intervention.. Also, no significant differences were found between numbers of desquamatedd cells.
Inn group I no follicular size irregularity, hyperplasia, adenoma, carcinoma, or any otherr malignancies were found, w T hich was significantly different from all other groups regardingg regularity in follicular size and presence of hyperplasia (table 2) . This was alsoo significantly different regarding adenoma compared to group II and V, but not to groupp III and IV The number of adenomas in group V was also significantly higher thann in group IV (p=0.039).
Inn the irradiated rats, 3 thyroid carcinomas were found, each in a group with a different endocrinee intervention. None of these 3 rats had metastases to the lungs, cervical lymphh nodes or liver. Furthermore, in 18 irradiated thyroid glands at least one lesion withh hyperplasia was found, in 11 at least one 1 adenoma, in 1 a thyroid cvst, and in 1 ii m
(8) III(T) )
IVV (8) VV (8) Sum: : Discussion n Exposuree to X-radiation in rats, 6 weeks of age, with 15 Gy single dose, leads to hypothyroidism,, follicular irregularity, thyrocyte hyperplasia and adenoma of the thyroid gland.. We could not confirm earlier results that lowering TSH during exposure to radiationn prevents hypothyroidism or the induction of thyroid neoplasms. In contrast, 544 weeks after radiation exposure, 3 thyroid carcinomas were observed in all three groupss that were given an endocrine intervention.
Thee first question is whether the dose of XR that we used was correct. Too high a dosee may damage all cells, blunting the occurrence of malignancies. In contrast, too loww a dose mav blunt the occurrence of hypothyroidism. An attempt was made to developp a model which can be linked to the radiation doses that are used in the clinical pediatricc setting after which both hypothyroidism and neoplasms are observed. One yearr after exposure to 15 Gy, it is seen that histologically and biochemically the rat thyroidd glands were not ablated indicating that this radiation dose was appropriate for studiess on hypothyroidism. No carcinoma developed in group II. This is however, nott probably caused by too high a dose as no severe damage of the thyroid cells was foundd at 6 weeks. Considering the fact that neoplasms did develop in the other groups, alsoo the follow-up time seems adequate.
AA second question is, whether the suppression of plasma TSH was sufficient. Inn our opinion, the development of a thyroid malignancy is the most severe late effect off radiation on the thyroid gland for the patient and also most important for medical care.. In case of a very high risk to develop a thyroid carcinoma, a preventive strategy thatt one could consider is to remove the thyroid gland prophylactically (surgical or withh radio-iodide). This would also imply life-long thyroxine supplementation, but
Endocnnoo inter vent ion for X-radiation protection of thr» thyroid thenn with the absolute certainty not to develop a thyroid malignancy. Supplementation off thyroxine to children without a thyroid is very well feasible: experience has been gainedd from children born without a thyroid gland (agenesis) and in children with the syndromee MEN-2A, whose thyroid is prophylactically removed for prevention of medullaryy thyroid carcinoma. For these reasons, the preventive strategy to administer life-longg T 4 and still a risk to develop a thyroid carcinoma is, in our opinion, not an optionn and we did not include such a study-group.
Off special attention is the fact that the levels of T^ are decreased with about 50 % Nextt to changes in histology, also chromosome aberrations and RET/PTC rearrangementss have been described to occur after radiation exposure 27, 28 . We did not includee molecular genetic studies for two reasons. Firstly, we wanted to examine to entiree gland for microscopy, because a local histological aberration could be present in justt one thyroid lobe. Secondly, although an increase of mainly RET/PTC-1 rearrangementss has been shown after external radiation 29 AA comment may be made on the fact that carcinoma developed in the groups with (slightly)) lower TSH during XR. This may suggest that our endocrine interventions havee "lowered" the threshold for radiation-exposure resulting in an increase of neoplasmss and a decrease of hypothyroidism (figure 3). If this is true, it would mean thatt endocrine intervention during irradiation (in rats but probably also in children) is moree disadvantageous than protective: inducing carcinoma instead of hypothyroidism.
Thee results of our study indicate that alternative ways than the administration of T 4
orr Na-1 should be searched for to prevent the thyroid against X-radiation. If the assumptionn is made that the presence of TSH is required for the development of thyroidd tumors, an alternative way to block the action of TSH is the administration of TSH-antagonists.. These compounds are mainly designated for the treatment of Graves' diseasee and TSH-secreting pituitary adenoma, but its possible radio-protective abilities shouldd also be examined in animal models 33 ' 34 . However, it must also be considered thatt TSH is not the only factor responsible for the thyroid tumor development. In a studyy performed on the relation between iodine-(in)sufficiency and tumor development afterr external radiation in rats also no relation was found between the level of TSH andd adenoma formation 35 . Insulin and Insulin-like growth factor (IGF) may be very importantt for tumor growth 36 . As also growth hormone is withdrawn by hypophysectomy,, this might explain why hypophysectomy is a more effective protection forr the development of thyroid tumors than the administration of T 4 -Another,, non-endocrine, pharmacological radio-protective intervention that may be consideredd is the administration of free radical scavengers. An example is amifostinc thatt has been shown to protect the salivary glands during X-radiation. No data on its protectivee action on the thyroid have been reported yet r . Also, other anti-oxidants or freee radical scavengers of which previous results indicate that they might be radioprotectivee for the thvroid gland, such as selenium, vitamin B, C or S-phencthyl formamidinoo 4 (N-ethvl isothiamide) morpholine dihydrochloride, a sulfur-containing compoundd 3S~41
, should be further evaluated in animal studies. However, an important aspectt that must be guarded, when protecting the thyroid from radiation with these non-thyroidd specific compounds, is that the malignancy itself is not protected against thee irradiation.
Wee could confirm the fact that an increased level of TSH during exposure to irradiation leadss to an increase in thyroid radiation damage in the group of rats that received Nal only.. The rise in TSH during ,2 "l" administration can be explained by the fall in T 4
reflectingg the acute Wolff-Chaikoff effect 24 -42 . In general, however, due to the escape ££ n d c o si ri L-intervention Uir X-fiïüï-ition protecifors of ihe-Jlvoiil mechanism,, the production of T 4 will quickly be restored and TSH and T 4 levels will nott be disturbed during exposure to excess iodine 43 . This short elevation of TSH duringg the administration of high doses of iodide can be explained by a failing escape mechanismm (more likely to be present in very young children or in the elderly). This phenomenonn of a failing escape-mechanism, together with the subsequently increased occurrencee in adenoma, should be a point of attention for those who administer high dosess of iodide for thyroid protection against radio-iodide to young children 44 .
Inn conclusion, endocrine inhibition of the thyroid's metabolic activity with the administrationn of T 4 , Nal or both during X-radiation docs not prevent radiation induced functionn loss or structural abnormalities of the thyroid gland in young Wistar rats.
Thiss implies that the current strategies undertaken to minimize radiation-exposure to thee thyroid gland must be continued (hyp erfraeti o nation, reduction of total radiation dosee and field, and applying lead shields) until novel preventive strategies evolve.
